Factors associated with long‐term outcomes in people with new onset refractory epilepticus: A single‐center cohort study
Epilepsia · 2025
DOI: 10.1111/epi.70004 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Epilepsia, 2025. Verfasst von Wei Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Status Epilepticus, Drug Resistant Epilepsy. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objective
New onset refractory status epilepticus (NORSE) is a neurologic emergency in people without a history of active epilepsy or other preexisting neurological disorders. There are not many studies reporting on the long‐term outcomes of NORSE. We investigate factors associated with outcomes such as mortality and sequelae in NORSE.
Methods
This retrospective, single‐center study involved individuals diagnosed with NORSE in West China hospital who were consecutively admitted between January 2018 and December 2022. The primary outcome was death at follow‐up. Secondary outcomes included functional recovery and sequelae among survivors. Lasso–Cox regression was used to evaluate factors for death. A Cox proportional hazard regression model was then established, incorporating several parameters identified through Lasso–Cox regression.
Results
One hundred one individuals with NORSE were identified and reviewed (median age = 30 years, 45 (45%) were female). The etiology was unknown in 37 (37%) people despite comprehensive diagnostic workups. Among the remaining 64 (64%), the most common etiology of NORSE was autoimmune encephalitis ( n = 53, 83%), followed by infectious encephalitis ( n = 9, 14%). One person died in‐hospital, and 24 (24%) died during follow‐up. Factors independently associated with death were the presence of superrefractory status epilepticus (hazard ratio [HR] = 3.99, 95% confidence interval [CI] = 1.09–14.61, p = .036) and initial response to immunotherapy (HR = .11, 95% CI = .02–.62, p = .012). The median follow‐up duration among the 76 survivors was 40 months (range = 24–82 months). Among them, functional recovery was achieved in 52 (68%) at the last follow‐up, whereas sequelae were seen in 24 people, the most common being active epilepsy ( n = 9, 12%). Significance The primary etiology in the NORSE cohort was autoimmune, followed by unknown causes. Response to immunotherapy is highly associated with long‐term mortality, even in those with unknown etiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
- Institute of Brain Science and Brain-Inspired Technology of West China Hospital, Sichuan University, Chengdu, China.
- University College London Queen Square Institute of Neurology, London, UK.
- Chalfont Centre for Epilepsy, Chalfont St Peter, UK.
ORCID-Profile: Wei Peng, Lu Lu, Jianqiong Yin, Ammar T Abdulaziz, Josemir W Sander, Jinmei Li, Dong Zhou
Zitieren
APA
Peng, W., Lu, L., Yin, J., Abdulaziz, A. T., Sander, J. W., Li, J., & Zhou, D. (2025). Factors associated with long‐term outcomes in people with new onset refractory epilepticus: A single‐center cohort study. Epilepsia. https://doi.org/10.1111/epi.70004
Vancouver
Peng W, Lu L, Yin J, Abdulaziz AT, Sander JW, Li J, et al. Factors associated with long‐term outcomes in people with new onset refractory epilepticus: A single‐center cohort study. Epilepsia. 2025. doi:10.1111/epi.70004
BibTeX
@article{Peng2025,
author = {Peng, Wei and Lu, Lu and Yin, Jianqiong and Abdulaziz, Ammar T and Sander, Josemir W and Li, Jinmei and Zhou, Dong},
title = {Factors associated with long‐term outcomes in people with new onset refractory epilepticus: A single‐center cohort study},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.70004}
}
EUVIMED